Literature DB >> 21990098

Primary and secondary CoQ(10) deficiencies in humans.

Catarina M Quinzii1, Michio Hirano.   

Abstract

CoQ(10) deficiencies are clinically and genetically heterogeneous. This syndrome has been associated with five major clinical phenotypes: (1) encephalomyopathy, (2) severe infantile multisystemic disease, (3) cerebellar ataxia, (4) isolated myopathy, and (5) nephrotic syndrome. In a few patients, pathogenic mutations have been identified in genes involved in the biosynthesis of CoQ(10) (primary CoQ(10) deficiencies) or in genes not directly related to CoQ(10) biosynthesis (secondary CoQ(10) deficiencies). Respiratory chain defects, ROS production, and apoptosis variably contribute to the pathogenesis of primary CoQ(10) deficiencies.
Copyright © 2011 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990098      PMCID: PMC3258494          DOI: 10.1002/biof.155

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  46 in total

1.  Progression despite replacement of a myopathic form of coenzyme Q10 defect.

Authors:  K Auré; J F Benoist; H Ogier de Baulny; N B Romero; O Rigal; A Lombès
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

2.  Acquired coenzyme Q10 deficiency in children with recurrent food intolerance and allergies.

Authors:  Michael V Miles; Philip E Putnam; Lili Miles; Peter H Tang; Antonius J DeGrauw; Brenda L Wong; Paul S Horn; Heather L Foote; Marc E Rothenberg
Journal:  Mitochondrion       Date:  2010-09-15       Impact factor: 4.160

3.  Human cultured skin fibroblasts survive profound inherited ubiquinone depletion.

Authors:  V Geromel; N Kadhom; I Ceballos-Picot; D Chrétien; A Munnich; A Rötig; P Rustin
Journal:  Free Radic Res       Date:  2001-07

4.  Familial cerebellar ataxia with muscle coenzyme Q10 deficiency.

Authors:  O Musumeci; A Naini; A E Slonim; N Skavin; G L Hadjigeorgiou; N Krawiecki; B M Weissman; C Y Tsao; J R Mendell; S Shanske; D C De Vivo; M Hirano; S DiMauro
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

5.  The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.

Authors:  M C Moreira; C Barbot; N Tachi; N Kozuka; E Uchida; T Gibson; P Mendonça; M Costa; J Barros; T Yanagisawa; M Watanabe; Y Ikeda; M Aoki; T Nagata; P Coutinho; J Sequeiros; M Koenig
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

6.  Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene.

Authors:  H Date; O Onodera; H Tanaka; K Iwabuchi; K Uekawa; S Igarashi; R Koike; T Hiroi; T Yuasa; Y Awaya; T Sakai; T Takahashi; H Nagatomo; Y Sekijima; I Kawachi; Y Takiyama; M Nishizawa; N Fukuhara; K Saito; S Sugano; S Tsuji
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

7.  Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency.

Authors:  M Gironi; C Lamperti; R Nemni; M Moggio; G Comi; F R Guerini; P Ferrante; N Canal; A Naini; N Bresolin; S DiMauro
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

8.  Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS deficiency.

Authors:  E Leshinsky-Silver; A Levine; A Nissenkorn; V Barash; M Perach; E Buzhaker; M Shahmurov; S Polak-Charcon; D Lev; T Lerman-Sagie
Journal:  Mol Genet Metab       Date:  2003-08       Impact factor: 4.797

9.  Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke.

Authors:  Tatjana Rundek; Ali Naini; Ralph Sacco; Kristen Coates; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2004-06

10.  Cerebellar ataxia and coenzyme Q10 deficiency.

Authors:  C Lamperti; A Naini; M Hirano; D C De Vivo; E Bertini; S Servidei; M Valeriani; D Lynch; B Banwell; M Berg; T Dubrovsky; C Chiriboga; C Angelini; E Pegoraro; S DiMauro
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

View more
  42 in total

Review 1.  Drug development for rare mitochondrial disorders.

Authors:  Orest Hurko
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 2.  Deafness and Vestibulopathy in Cerebellar Diseases: a Practical Approach.

Authors:  Orlando G Barsottini; José Luiz Pedroso; Carlos Roberto Martins; Marcondes Cavalcante França; Pedro Mangabeira Albernaz
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

3.  Pathomechanisms in coenzyme q10-deficient human fibroblasts.

Authors:  Luis C López; Marta Luna-Sánchez; Laura García-Corzo; Catarina M Quinzii; Michio Hirano
Journal:  Mol Syndromol       Date:  2014-07

4.  Coenzyme q10 therapy.

Authors:  Juan Garrido-Maraver; Mario D Cordero; Manuel Oropesa-Ávila; Alejandro Fernández Vega; Mario de la Mata; Ana Delgado Pavón; Manuel de Miguel; Carmen Pérez Calero; Marina Villanueva Paz; David Cotán; José A Sánchez-Alcázar
Journal:  Mol Syndromol       Date:  2014-07

5.  An overview of current mouse models recapitulating coenzyme q10 deficiency syndrome.

Authors:  Floriana Licitra; Hélène Puccio
Journal:  Mol Syndromol       Date:  2014-07

Review 6.  Current concepts in the treatment of hereditary ataxias.

Authors:  Pedro Braga Neto; José Luiz Pedroso; Sheng-Han Kuo; C França Marcondes Junior; Hélio Afonso Ghizoni Teive; Orlando Graziani Povoas Barsottini
Journal:  Arq Neuropsiquiatr       Date:  2016-03       Impact factor: 1.420

7.  Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis.

Authors:  Ying Wang; Daniella Oxer; Siegfried Hekimi
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

Review 8.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

9.  Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability.

Authors:  Lubov Blumkin; Esther Leshinsky-Silver; Ayelet Zerem; Keren Yosovich; Tally Lerman-Sagie; Dorit Lev
Journal:  JIMD Rep       Date:  2013-09-19

10.  Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study.

Authors:  Andrea Coppadoro; Lorenzo Berra; Asheesh Kumar; Riccardo Pinciroli; Marina Yamada; Ulrich H Schmidt; Edward A Bittner; Masao Kaneki
Journal:  J Crit Care       Date:  2013-04-22       Impact factor: 3.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.